- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||dectrekumab|
|Search PubMed titles||dectrekumab|
|Search PubMed titles/abstracts||dectrekumab|
|Dectrekumab is a fully human investigational anti-interleukin 13 (IL-13) monoclonal antibody, with anti-inflammatory potential.
Peptide sequence and secondary structural information are available from dectrekumab's IMGT/mAb-DB record.
Peptide sequences for the heavy and light chains of dectrekumab match those provided in patent US8992916 B2 for clone 01951/G12 .